A novel mutation in the transmembrane region of glycoprotein IX associated with Bernard-Soulier syndrome

Summary

We describe here a novel mutation in glycoprotein (GP) IX transmembrane region in a patient with Bernard-Soulier syndrome (BSS). Flow cytometric analysis of the patient’s platelets showed that GP Iba and GP IX were expressed at decreased levels. Sequence analysis of the gene coding for GP IX revealed a homozygous (G to A) transition at nucleotide 2113, resulting in a Ala 140 (GCC) to Thr (ACC) replacement in the mature peptide, whereas no defects were found in the coding region of the GP Iba and GP Ib? gene. Allele-specific restriction enzyme analysis using HPYCH4 III revealed that the patient was homozygous and her mother and brother were heterozygous for the defect, and excluded the possibility that the mutation was a polymorphism of GP IX.To clarify the effect of this mutation on the surface expression of the GP Ib/IX complex, we introduced this mutation into the cDNA of GP IX by site-directed mutagenesis and performed in vitro transfection studies with plasmids harboring GP Iba, GP Ib? and wild-type GP IX or mutant GP IX. Mutant GP IX decreased the surface expression of GP Iba and GP IX, whereas both immunostaining and immunoblotting of the transfected Chinese hamster ovary (CHO) cells showed abundant GP Iba and GP IX in the cytoplasm of the CHO cells transfected with plasmids harboring GP Iba, GP Ib? and wild-type GP IX or mutant GP IX These findings indicate that the Ala140→Thr mutation in the transmembrane region of GP IX does not induce intracellular GP Ib/IX complex degradation, but prevents its insertion in the cytoplasmic membrane of platelets and CHO cells.

Keywords

Bernard-Soulier syndrome - platelet - glycoprotein - gene - mutation

• References

• 1 Bernard J, Soulier JP. Sur une nouvelle variete de dystrophie thrombocytaire-hemorragipare congenitale. Semin Hop Paris 1948; 24: 3217-23.
• 2 Weiss HJ, Tschopp TB, Baumgartner HR. et al. Decreased adhesion of giant (BernardSoulier) platelets to subendothelium Further implications on the role of the von Willebrand factor in hemostasis. Am J Med 1974; 57: 920-5.
• 3 Nurden AT, Caen JP. Specific roles for platelet surface glycoproteins in platelet function. Nature 1975; 255: 720-2.
• 4 Clemetson KJ, McGregor JL, James E. et al. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 1982; 70: 304-11.
• 5 Berndt MC, Gregory C, Chong BH. et al. Additional glycoprotein defects in BernardSoulier’s syndrome: Confirmation of genetic basis by parental analysis. Blood 1983; 62: 800-7.
• 6 Caen JP, Nurden AT, Jeanneau C. et al. Bernard-Soulier syndrome A new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. J Lab Clin Med 1976; 87: 586-96.
• 7 Sakariassen KS, Nievelstein PF, Coller BS. et al. The role of platelet membrane glycoprotein Ib and IIb-IIIa in platelet adherence to human artery subendthelium. Br J Haematol 1986; 63: 681-91.
• 8 Lopez JA. The platelet glycoprotein GP Ib/IX complex. Blood Coagul Fibrinolysis 1994; 05: 97-119.
• 9 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-97.
• 10 Kroll MH, Hellums JD, McIntire LV. et al. Platelets and shear stress. Blood 1996; 88: 1525-41.
• 11 Du X, Beutler L, Ruan C. et al. Glycoprotein IB and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 1987; 69: 1524-7.
• 12 Modderman PW, Admiraal LG, Sonnenberg A. et al. Glycoprotein V and I-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992; 267: 364-9.
• 13 Lopez JA, Weisman S, Sanan DA. et al. Glycoprotein (GP) Iba is the critical subunit linking GP Iba and GPIX in the GP Ib-IX complex Analysis of partial complexs. J Biol Chem 1994; 269: 23716-21.
• 14 Michelson AD, Benoit SE, Furman MI. et al. The platelet surface expression of glycoprotein V is regulated by two independent mechanisms: Proteolysis and the reversible cytoskeletal-mediated redistribution to the surface-connected canalicular system. Blood 1996; 87: 1396.
• 15 Wu G, Essex DW, Meloni FJ. et al. Human endothelial cells in culture and in vivo express on their surface all four components of the glycoprotein Ib/IX/V complex. Blood 1997; 90: 2660-9.
• 16 Kobe B, Deisenhofer J. The leucine-rich repeat: A versatile binding motif. Trends Biochem Sci 1994; 19: 415-21.
• 17 Phillips DR, Agin PP. Platelet plasma membrane glycoproteins Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis. J Biol Chem 1997; 252: 2121-6.
• 18 Ward CM, Andrews RK, Smith AI. et al. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein GP Iba Identification of the sulfated tyrosine/anionic sequence Tyr-276–Glu-282 of glycoprotein GP Iba as a binding site for von Willebrand factor and a-thrombin. Biochemistry 1996; 35: 4929-38.
• 19 Vicente V, Kostel PJ, Ruggeri ZM. Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the a-chain of glycoprotein Ib. J Biol Chem 1988; 263: 18473-9.
• 20 Andrews RK, Booth WJ, Gorman JJ. et al. Purification of botrocetin from bothrops jararaca venom Analysis of the botrocetinmediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1989; 28: 8317-26.
• 21 De Marco L, Mazzucato M, Masotti A. et al. Localization and characterization of an a–thrombin-binding site on platelet glycoprotein Iba . J Biol Chem 1994; 269: 6478-84.
• 22 Lopez JA, Leung B, Reynolds CC. et al. Efficient plasma membrane expression of a functional platelet glycoprotein Ib-IX complex requires the presence of its three subunits. J Biol Chem 1992; 267: 12851-9.
• 23 Wright SD, Michaelides K, Johnson DJ. et al. Double heterozygosity for mutations in the platelet glycoprotein IX gene in three siblings with Bernard-Soulier syndrome. Blood 1993; 81: 2339-47.
• 24 Noda M, Fujimura K, Takafuta T. et al. Heterogenous expression of glycoprotein Ib, IX and V in platelets from two patients with Bernard-Soulier syndrome caused by different genetic abnormalities. Thromb Haemost 1995; 74: 1411-5.
• 25 Ludlow LB, Schick BP, Budarf ML. et al. Identification of a mutation in a GATA binding site of the platelet glycoprotein Ib? promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 1996; 271: 2207680.
• 26 Calverley DC, Yagi M, Stray SM. et al. Human platelet glycoprotein V Its role in enhancing expression of the glycoprotein Ib receptor. Blood 1995; 86: 1361-7.
• 27 Lopez JA, Andrew RK, Afshar-Kharghan V. et al. Bernard-Soulier syndrome. Blood 1998; 91: 4397-18.
• 28 Lanza F, de la CSalle, Baas MJ. et al. A Leu7Pro mutation in the signal peptide of platelet glycoprotein (GP) IX in a case of Bernard-Soulier syndrome abolishes surface expression of the GP Ib-IX-V complex. Br J Haematol 2002; 118: 260-6.
• 29 Ciulla TA, Sklan RM, Hauser SL. A simple method for DNA purification from peripheral blood. Analytical Biochemistry 1988; 174: 485-8.
• 30 Hayashi T, Suzuki K, Yahagi A. et al. Corrected DNA sequence of the platelet glycoprotein IX gene. Thromb Haemost 1997; 77: 1034-5.
• 31 Rivera CE, Villagra J, Riordan M. et al. Identification of a new mutation in platelet glycoprotein IX (GPIX) in a patient with Bernard-Soulier syndrome. Br J Haematol 2001; 112: 105-8.
• 32 Noris P, Arbustini E, Spedini P. et al. A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) Ib and severely reduced amounts of GPIX and GPV. Br J Haematol 1998; 103: 1004-13.
• 33 Clemetson JM, Kyrie PA, Brenner B. et al. Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucinerich domain of glycoprotein IX. Blood 1994; 84: 1124-31.
• 34 Sae-Tung G, Dong J, Lopez JA. Biosynthetic defect in platelet glycoprotein IX mutants associated with Bernard-Soulier syndrome. Blood 1996; 87: 1361-7.
• 35 Noris P, Simsek S, Stibbe J, von dem Borne AEG. A phenylalanine-55 to serine aminoacid substitution in the human glycoprotein IX leucine-rich repeat is associated with BernardSoulier syndrome. Br J Haematol 1997; 97: 31220.
• 36 Suzuki K, Hayashi T, Yahagi A. et al. Novel point mutation in the leucine-rich motif of the platelet glycoprotein IX associated with Bernard-Soulier syndrome. Br J Haematol 1997; 99: 794-800.
• 37 Noda M, Fujimura K, Takafuta T. et al. A point mutation in glycoprotein IX coding sequence (Cys73 (TGT) to Tyr (TAT)) causes impaired surface expression of GP Ib-IX-V complex in two families with Bernard-Soulier syndrome. Thromb Haemost 1996; 06: 874-8.
• 38 Kunishima S, Tomiyama Y, Honda S, et a. Cys97→Tyr mutation in the GP IX gene associated with Bernard-Soulier syndrome. Br J Haematol 1999; 107: 539-45.
• 39 Iwanaga M, Kunishima S, Ikeda S. et al. Vulnerable mutation Trp126→stop of glycoprotein IX in Japanese Bernard-Soulier syndrome. Eur J Haematol 1998; 60: 264-6.
• 40 Sachs UJ, Kroll H, Matzdorff AC. et al. Bernard-Soulier syndrome due to the homozygous Asn-45Ser mutation in GPIX: an unexpected, frequent finding in Germany. Br J Haematol 2003; 123: 127-31.
• 41 Dong JF, Gao S, Lopez JA. Synthesis, assembly, and intracellular transport of the platelet glycoprotein Ib-IX-V complex. J Biol Chem 1998; 273: 31449-54.
• 42 Afshar-Kharghan V, Lopez JA. BernardSoulier syndrome caused by a dinucleotide deletion and reading frameshift in the region encoding the glycoprotein Iba transmembrane domain. Blood 1997; 90: 2634-43.